Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Developed as diabetes drugs, they essentially slow down the emptying of the stomach
Abstract Purpose of Review This review explores the rationale and available evidence behind incretin-based therapies for metabolic dysfunction-associated steatotic disease (MASLD) and metabolic-associated steatohepatitis (MASH), focusing on glucagon-like peptide 1 (GLP-1) and glucagon (GCG) receptor dual agonists (GLP-1/GCG RAs)
A review of available medical therapies to treat moderate-to-severe inflammatory bowel disease
According to the oxidative stress theory of aging, the accumulation of harmful reactive oxygen and nitrogen free radicals leads to age-related functional impairments
US$ 21.76
US$ 21.12
US$ 21.49
US$ 20.52
US$ 26.53
US$ 29.07
US$ 21.46
US$ 29.30
US$ 20.45
US$ 23.83
